DYAI (Dyadic International) Gross Margin % : 56.92% (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Dyadic International Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Dyadic International's Gross Profit for the three months ended in Dec. 2024 was $0.47 Mil. Dyadic International's Revenue for the three months ended in Dec. 2024 was $0.82 Mil. Therefore, Dyadic International's Gross Margin % for the quarter that ended in Dec. 2024 was 56.92%.

The historical rank and industry rank for Dyadic International's Gross Margin % or its related term are showing as below:

DYAI' s Gross Margin % Range Over the Past 10 Years
Min: 10.29 Med: 19.89 Max: 65.85
Current: 65.85

During the past 13 years, the highest Gross Margin % of Dyadic International was 65.85%. The lowest was 10.29%. And the median was 19.89%.

DYAI's Gross Margin % is ranked better than
56.6% of 742 companies
in the Biotechnology industry
Industry Median: 59.925 vs DYAI: 65.85

Dyadic International had a gross margin of 56.92% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Dyadic International was 39.30% per year.

Dyadic International Gross Margin % Historical Data

The historical data trend for Dyadic International's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dyadic International Gross Margin % Chart

Dyadic International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross Margin %

Get a 7-Day Free Trial

11.05

19.09

27.54

31.84

65.84

Dyadic International Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Gross Margin %	Get a 7-Day Free Trial															48.91	57.01	21.76	79.78	56.92

Competitive Comparison of Dyadic International's Gross Margin %

For the Biotechnology subindustry, Dyadic International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dyadic International's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dyadic International's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Dyadic International's Gross Margin % falls into.

Save Embed

;

Save Embed

;

Dyadic International Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Dyadic International's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )	=	Gross Profit (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	2.3	/	3.495
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(3.495 - 1.194)	/	3.495
	=	65.84 %

Dyadic International's Gross Margin for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )	=	Gross Profit (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0.5	/	0.817
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.817 - 0.352)	/	0.817
	=	56.92 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Dyadic International (NAS:DYAI) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Dyadic International had a gross margin of 56.92% for the quarter that ended in Dec. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Dyadic International Gross Margin % Related Terms

Thank you for viewing the detailed overview of Dyadic International's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dyadic International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dyadic International Inc (NAS:DYAI) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1044 North U.S. Highway One, Suite 201, Jupiter, FL, USA, 33477

Website

https://www.dyadic.com

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Executives

Ronen Tchelet	officer: VP of Research and Bus. Dvlpmt	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Mark A Emalfarb	director, 10 percent owner, officer: President, CEO & Chairman	C/O DYADIC INTERNATIONAL, INC., 140 INTRACOASTAL POINT DRIVE, SUITE 404, JUPITER FL 33477-5094
Joseph P Hazelton	officer: Chief Business Officer	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER FL 33477
Francisco Trust Under Agreement Dated February 28, 1996	10 percent owner	C/O ROBERT S. LEVIN, ESQ., TRUSTEE, 180 NORTH LASALLE STREET, SUITE 3200, CHICAGO IL 60601
Patrick K. Lucy	director	C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Matthew S. Jones	officer: Managing Dir of BD & Licensing	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Seth Herbst	director	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Barry Buckland	director	C/O DYADIC INTERNATIONAL, INC., 140 INTERCOASTAL POINTE DR SUITE 404, JUPITER FL 33477
Ping Wang Rawson	officer: Chief Financial Officer	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Michael P. Tarnok	director	KERYX BIOPHARMACEUTICALS, INC., 750 LEXINGTON AVENUE, NEW YORK NY 10022
Arindam Bose	director	4452 BELTWAY DRIVE, ADDISON TX 75001
Jack Kaye	director	C/O KERYX BIOPHARMACEUTICALS, 750 LEXINGTON AVENUE, NEW YORK X1 10022
Tom Juda	10 percent owner	410 S LUCERNE BLVD, LOS ANGELES CA 90020
John Steven Emerson	10 percent owner	1522 ENSLEY AVENUE, LOS ANGELES CA 90024
Nancy Juda	10 percent owner	410 S LUCERNE BLVD, LOS ANGELES CA 90020